Literature DB >> 3516086

Fibrin in peritonitis. V. Fibrin inhibits phagocytic killing of Escherichia coli by human polymorphonuclear leukocytes.

O D Rotstein, T L Pruett, R L Simmons.   

Abstract

Fibrin deposition initiated by peritonitis is thought to be an important local defense mechanism because it sequesters and walls off bacterial spillage. However, fibrin has been shown to predispose to residual abscess formation in rat peritonitis model. To examine the potential mechanisms of this effect, fibrin was tested in vitro for its inhibitory effect on neutrophil function. At all concentrations tested (50-1000 mg/dl), fibrin significantly impaired the ability of neutrophils to kill Escherichia coli. This inhibition occurred in a dose dependent fashion with almost complete prevention of killing at the highest concentration tested. Further studies showed that pre-exposure to fibrin did not reduce the neutrophil's ability to degranulate, undergo a respiratory burst, or kill E. coli, indicating that fibrin did not cause irreversible damage to the normal microbicidal functions of the neutrophil. However, fibrin, at physiologic concentrations, significantly impaired phagocytosis of radiolabeled E. coli. The data support the concept that phagocytosis of bacteria is impaired by neutrophils enmeshed in fibrin. Thus, contaminated fibrin could act as a nidus for residual abscesses formation following peritonitis even if an adequate number of normal leukocytes were present.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3516086      PMCID: PMC1251127          DOI: 10.1097/00000658-198604000-00013

Source DB:  PubMed          Journal:  Ann Surg        ISSN: 0003-4932            Impact factor:   12.969


  34 in total

1.  Experimental study of physical factors, including fibrin formation, influencing the spread of fluids and small particles within and from the peritoneal cavity of the dog.

Authors:  H H ZINSSER; A W PRYDE
Journal:  Ann Surg       Date:  1952-11       Impact factor: 12.969

Review 2.  Secondary bacterial peritonitis: the biologic basis of treatment.

Authors:  T Hau; D H Ahrenholz; R L Simmons
Journal:  Curr Probl Surg       Date:  1979-10       Impact factor: 1.909

3.  Absorption from the peritoneal cavity: SEM study of the mesothelium covering the peritoneal surface of the muscular portion of the diaphragm.

Authors:  E C Tsilibary; S L Wissig
Journal:  Am J Anat       Date:  1977-05

4.  The influence of contact guidance on chemotaxis of human neutrophil leukocytes.

Authors:  P C Wilkinson; J M Lackie
Journal:  Exp Cell Res       Date:  1983-05       Impact factor: 3.905

5.  A rapid one-step procedure for purification of mononuclear and polymorphonuclear leukocytes from human blood using a modification of the Hypaque-Ficoll technique.

Authors:  A Ferrante; Y H Thong
Journal:  J Immunol Methods       Date:  1978       Impact factor: 2.303

6.  Separation and characterization of human neutrophil granules.

Authors:  B C West; A S Rosenthal; N A Gelb; H R Kimball
Journal:  Am J Pathol       Date:  1974-10       Impact factor: 4.307

7.  The adjuvant effect of peritoneal fluid in experimental peritonitis. Mechanism and clinical implications.

Authors:  D L Dunn; R A Barke; D H Ahrenholz; E W Humphrey; R L Simmons
Journal:  Ann Surg       Date:  1984-01       Impact factor: 12.969

8.  Fibrinolytic activity of the peritoneum during experimental peritonitis.

Authors:  T Hau; W D Payne; R L Simmons
Journal:  Surg Gynecol Obstet       Date:  1979-03

9.  Mechanisms of the adjuvant effect of hemoglobin in experimental peritonitis. VII. Hemoglobin does not inhibit clearance of Escherichia coli from the peritoneal cavity.

Authors:  D L Dunn; R A Barke; J T Lee; R M Condie; E W Humphrey; R L Simmons
Journal:  Surgery       Date:  1983-09       Impact factor: 3.982

10.  The effect of heparin upon fibrinopurulent peritonitis in rats.

Authors:  G Chalkiadakis; A Kostakis; P E Karayannacos; H Giamarellou; I Dontas; I Sakellariou; G D Skalkeas
Journal:  Surg Gynecol Obstet       Date:  1983-09
View more
  14 in total

1.  Platelet-activating factor modulates endotoxin-induced macrophage procoagulant activity by a protein kinase C-dependent mechanism.

Authors:  D S Kucey; P Y Cheung; O D Rotstein
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

2.  A highly elastic and adhesive gelatin tissue sealant for gastrointestinal surgery and colon anastomosis.

Authors:  Tony Vuocolo; Roger Haddad; Glenn A Edwards; Russell E Lyons; Nancy E Liyou; Jerome A Werkmeister; John A M Ramshaw; Christopher M Elvin
Journal:  J Gastrointest Surg       Date:  2011-11-12       Impact factor: 3.452

Review 3.  Operative management of intraabdominal infection.

Authors:  C Aprahamian; D H Wittmann
Journal:  Infection       Date:  1991 Nov-Dec       Impact factor: 3.553

Review 4.  Role of fibrin deposition in the pathogenesis of intraabdominal infection.

Authors:  O D Rotstein
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-11       Impact factor: 3.267

5.  Tissue plasminogen activator reverses the deleterious effect of infection on colonic wound healing.

Authors:  K A Houston; D I McRitchie; O D Rotstein
Journal:  Ann Surg       Date:  1990-02       Impact factor: 12.969

Review 6.  Principles and limitations of operative management of intraabdominal infections.

Authors:  E H Farthmann; U Schöffel
Journal:  World J Surg       Date:  1990 Mar-Apr       Impact factor: 3.352

7.  Fibrin in peritonitis.

Authors:  V E Muntean
Journal:  Ann Surg       Date:  1987-11       Impact factor: 12.969

8.  [Early phase of healing of anastomoses with special reference to peritonitis and ischemia].

Authors:  D Wilker; J Sklarek; H Waldner; J R Izbicki; M Siebeck
Journal:  Langenbecks Arch Chir       Date:  1988

9.  Disparate mechanisms of induction of procoagulant activity by live and inactivated bacteria and viruses.

Authors:  S B Sinclair; O D Rotstein; G A Levy
Journal:  Infect Immun       Date:  1990-06       Impact factor: 3.441

Review 10.  Anastomoses of the lower gastrointestinal tract.

Authors:  Govind Nandakumar; Sharon L Stein; Fabrizio Michelassi
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2009-11-03       Impact factor: 46.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.